EE200000186A - Osake, selliste osakeste valmistamismeetod ja kasutamine, farmatseutiline doosivorm ja selle valmistamismeetod, tahke dispersioon ja farmatseutiline pakend - Google Patents
Osake, selliste osakeste valmistamismeetod ja kasutamine, farmatseutiline doosivorm ja selle valmistamismeetod, tahke dispersioon ja farmatseutiline pakendInfo
- Publication number
- EE200000186A EE200000186A EEP200000186A EEP200000186A EE200000186A EE 200000186 A EE200000186 A EE 200000186A EE P200000186 A EEP200000186 A EE P200000186A EE P200000186 A EEP200000186 A EE P200000186A EE 200000186 A EE200000186 A EE 200000186A
- Authority
- EE
- Estonia
- Prior art keywords
- pharmaceutical
- particle
- preparing
- particles
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97203407 | 1997-11-03 | ||
| PCT/EP1998/006998 WO1999022738A1 (en) | 1997-11-03 | 1998-10-27 | Compositions of lipid lowering agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200000186A true EE200000186A (et) | 2001-04-16 |
Family
ID=8228898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000186A EE200000186A (et) | 1997-11-03 | 1998-10-27 | Osake, selliste osakeste valmistamismeetod ja kasutamine, farmatseutiline doosivorm ja selle valmistamismeetod, tahke dispersioon ja farmatseutiline pakend |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6342245B1 (xx) |
| EP (1) | EP1028730B1 (xx) |
| JP (1) | JP2001521899A (xx) |
| KR (2) | KR20010023661A (xx) |
| CN (1) | CN1278175A (xx) |
| AR (1) | AR013739A1 (xx) |
| AT (1) | ATE216238T1 (xx) |
| AU (1) | AU746890B2 (xx) |
| BG (1) | BG104338A (xx) |
| BR (1) | BR9814109A (xx) |
| CA (1) | CA2307097A1 (xx) |
| DE (1) | DE69804994D1 (xx) |
| EE (1) | EE200000186A (xx) |
| HU (1) | HUP0004139A3 (xx) |
| NO (1) | NO20002279L (xx) |
| NZ (1) | NZ503413A (xx) |
| PL (1) | PL340305A1 (xx) |
| SK (1) | SK5972000A3 (xx) |
| WO (1) | WO1999022738A1 (xx) |
| ZA (1) | ZA989997B (xx) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE444060T1 (de) | 2001-06-22 | 2009-10-15 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren |
| US20030059487A1 (en) * | 2001-09-21 | 2003-03-27 | Niazi Sarfaraz K. | Composition and method for the treatment of hypercholesterolemia and hyperlipidemia in mammals |
| US20040220240A1 (en) * | 2001-11-28 | 2004-11-04 | Pellegrini Cara A. | Method of increasing the extent of absorption of tizanidine |
| US6455557B1 (en) * | 2001-11-28 | 2002-09-24 | Elan Pharmaceuticals, Inc. | Method of reducing somnolence in patients treated with tizanidine |
| NZ546183A (en) * | 2003-09-26 | 2011-04-29 | Alza Corp | Controlled release formulations exhibiting an ascending rate of release |
| ATE504288T1 (de) * | 2003-09-26 | 2011-04-15 | Alza Corp | Oros-push-stick für die kontrollierte abgabe von wirkstoffen |
| JP5563731B2 (ja) * | 2003-09-26 | 2014-07-30 | アルザ・コーポレーシヨン | オピオイドおよび非オピオイド鎮痛薬の制御放出製剤 |
| JP4919801B2 (ja) * | 2003-09-26 | 2012-04-18 | アルザ・コーポレーシヨン | 高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法 |
| CN101664411A (zh) | 2003-11-14 | 2010-03-10 | 味之素株式会社 | 苯丙氨酸衍生物的固体分散体或固体分散体医药制剂 |
| WO2005097131A2 (en) * | 2004-04-09 | 2005-10-20 | Janssen Pharmaceutica N.V. | Intermittent dosing regimen for the treatment of overweight with mtp-inhibitors |
| WO2005117834A1 (en) * | 2004-05-27 | 2005-12-15 | Janssen Pharmaceutica N.V. | Solid dispersions of a basic drug compound and a polymer containing acidic groups |
| US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
| KR100582347B1 (ko) * | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법 |
| CA2609783A1 (en) * | 2005-05-27 | 2006-12-07 | Pfizer Products Inc. | Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss |
| US20090028938A1 (en) * | 2005-08-08 | 2009-01-29 | Abbott Gmbh & Co. Kg | Dosage forms with improved bioavailability |
| EP1938804A1 (en) * | 2006-12-22 | 2008-07-02 | Novartis AG | Pharmaceutical formulation comprising neurokinin antagonist |
| DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
| WO2010143199A1 (en) | 2009-06-11 | 2010-12-16 | Suven Nishtaa Pharma Private Limited | Solid lipid dispersion for aqueous solubility enhancement of poorly water soluble drugs |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO118715B1 (ro) * | 1994-10-27 | 2003-09-30 | Janssen Pharmaceutica Nv | Inhibitori ai sintezei apolipoproteinei-b |
| US5521186A (en) * | 1994-10-27 | 1996-05-28 | Janssen Pharmaceutica N.V. | Apolipoprotein-β synthesis inhibitors |
-
1998
- 1998-10-27 EP EP98954483A patent/EP1028730B1/en not_active Expired - Lifetime
- 1998-10-27 DE DE69804994T patent/DE69804994D1/de not_active Expired - Lifetime
- 1998-10-27 WO PCT/EP1998/006998 patent/WO1999022738A1/en not_active Application Discontinuation
- 1998-10-27 EE EEP200000186A patent/EE200000186A/xx unknown
- 1998-10-27 PL PL98340305A patent/PL340305A1/xx unknown
- 1998-10-27 KR KR1020007002314A patent/KR20010023661A/ko not_active Application Discontinuation
- 1998-10-27 SK SK597-2000A patent/SK5972000A3/sk unknown
- 1998-10-27 NZ NZ503413A patent/NZ503413A/en unknown
- 1998-10-27 JP JP2000518671A patent/JP2001521899A/ja not_active Withdrawn
- 1998-10-27 AT AT98954483T patent/ATE216238T1/de not_active IP Right Cessation
- 1998-10-27 BR BR9814109-0A patent/BR9814109A/pt not_active IP Right Cessation
- 1998-10-27 CN CN98810808A patent/CN1278175A/zh active Pending
- 1998-10-27 US US09/530,170 patent/US6342245B1/en not_active Expired - Fee Related
- 1998-10-27 HU HU0004139A patent/HUP0004139A3/hu unknown
- 1998-10-27 KR KR1020007002383A patent/KR20010023729A/ko active Search and Examination
- 1998-10-27 CA CA002307097A patent/CA2307097A1/en not_active Abandoned
- 1998-10-27 AU AU11576/99A patent/AU746890B2/en not_active Ceased
- 1998-11-02 AR ARP980105502A patent/AR013739A1/es not_active Application Discontinuation
- 1998-11-02 ZA ZA9809997A patent/ZA989997B/xx unknown
-
2000
- 2000-04-14 BG BG104338A patent/BG104338A/xx unknown
- 2000-04-28 NO NO20002279A patent/NO20002279L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1028730A1 (en) | 2000-08-23 |
| AU1157699A (en) | 1999-05-24 |
| WO1999022738A1 (en) | 1999-05-14 |
| NZ503413A (en) | 2001-06-29 |
| SK5972000A3 (en) | 2000-12-11 |
| KR20010023661A (ko) | 2001-03-26 |
| US6342245B1 (en) | 2002-01-29 |
| PL340305A1 (en) | 2001-01-29 |
| DE69804994D1 (de) | 2002-05-23 |
| BR9814109A (pt) | 2000-10-03 |
| HUP0004139A3 (en) | 2002-03-28 |
| JP2001521899A (ja) | 2001-11-13 |
| NO20002279D0 (no) | 2000-04-28 |
| NO20002279L (no) | 2000-04-28 |
| BG104338A (en) | 2000-12-29 |
| ATE216238T1 (de) | 2002-05-15 |
| KR20010023729A (ko) | 2001-03-26 |
| EP1028730B1 (en) | 2002-04-17 |
| AR013739A1 (es) | 2001-01-10 |
| HUP0004139A2 (hu) | 2002-02-28 |
| CN1278175A (zh) | 2000-12-27 |
| AU746890B2 (en) | 2002-05-02 |
| CA2307097A1 (en) | 1999-05-14 |
| ZA989997B (en) | 2000-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE03902B1 (et) | Osakesed, nende valmistamismeetod ja kasutamine, farmatseutiline doseerimisvorm ja selle valmistamismeetod, tahke dispersioon ning farmatseutiline pakend | |
| EE200000186A (et) | Osake, selliste osakeste valmistamismeetod ja kasutamine, farmatseutiline doosivorm ja selle valmistamismeetod, tahke dispersioon ja farmatseutiline pakend | |
| EE200200151A (et) | Osake, ravimvorm, nende valmistamismeetodid, osakeste kasutamine ning farmatseutiline pakend | |
| EE04996B1 (et) | Reguleeritud vabanemisega galantamiinipreparaat, meetod selle valmistamiseks, seda sisaldav doseerimisvorm ning farmatseutiline pakend | |
| EE04042B1 (et) | Suure bioomastatavusega fenofibraatide ravimkoostis ja meetod selle valmistamiseks | |
| AU5936400A (en) | Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same | |
| WO2002043702A3 (en) | Pharmaceutical compositions for inhalation | |
| HUP0003990A3 (en) | Methods of treating capsules and dry, powdered pharmaceutical formulations | |
| IL143580A0 (en) | Pharmaceutical compositions containing lipophilic drugs and methods for the preparation thereof | |
| HUP0100562A3 (en) | Spheroids method for their preparation and pharmaceutical compositions containing them | |
| IL116674A (en) | Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof | |
| HUP0100266A3 (en) | 1-amino-alkylcyclohexane nmda receptor antagonists, pharmaceutical compositions containing the compounds and their preparations | |
| HUP0004024A3 (en) | Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof | |
| AU1606600A (en) | Apparatus and method for desiccating and deagglomerating wet, particulate materials | |
| HUP0104687A3 (en) | Methods for preparing coated drug particles and pharmaceutical formulations thereof | |
| HUP0200309A3 (en) | Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them | |
| EE9800269A (et) | Tahke doseerimisvorm, selle valmistamismeetod, seda sisaldav produkt, tablett ja farmatseutiline pakend ning tsisapriidisoolade kasutamine | |
| HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
| AU1307399A (en) | Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same | |
| HUP0002300A3 (en) | Quinoline-4-carboxamide derivatives, process for producing them, pharmaceutical compositions containing them and their use | |
| EE04119B1 (et) | Külmkuivatamiseks sobiv ravimkoostis ja selle valmistamise meetod | |
| EE200300153A (et) | Östrogeeni retseptori modulaatorid, farmatseutiline kompositsioon ja selle valmistamismeetod | |
| AU7201298A (en) | Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it | |
| FI960316A (fi) | Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| EE03996B1 (et) | Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine |